143 related articles for article (PubMed ID: 21864866)
1. Combined hypertriglyceridemic and insulin-glucose clamps for the characterization of substrate oxidation and plasma elimination of a long-chain triglyceride emulsion in healthy men.
Åberg V; Thörne A; Alvestrand A; Nordenström J
Metabolism; 2012 Feb; 61(2):221-8. PubMed ID: 21864866
[TBL] [Abstract][Full Text] [Related]
2. The hypertriglyceridemic clamp technique. Studies using long-chain and structured triglyceride emulsions in healthy subjects.
Nordenström J; Thörne A; Aberg W; Carneheim C; Olivecrona T
Metabolism; 2006 Nov; 55(11):1443-50. PubMed ID: 17046545
[TBL] [Abstract][Full Text] [Related]
3. Fat oxidation and plasma removal capacity of an intravenous fat emulsion in elderly and young men.
Aberg W; Thörne A; Olivecrona T; Nordenström J
Nutrition; 2006; 22(7-8):738-43. PubMed ID: 16815487
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of acute hypertriglyceridemia on insulin action and insulin receptor autophosphorylation.
Gumbiner B; Mucha JF; Lindstrom JE; Rekhi I; Livingston JN
Am J Physiol; 1996 Mar; 270(3 Pt 1):E424-9. PubMed ID: 8638688
[TBL] [Abstract][Full Text] [Related]
5. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM
Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474
[TBL] [Abstract][Full Text] [Related]
6. Relationship between insulin-mediated glucose disposal and lipid metabolism in man.
Lillioja S; Bogardus C; Mott DM; Kennedy AL; Knowler WC; Howard BV
J Clin Invest; 1985 Apr; 75(4):1106-15. PubMed ID: 3886702
[TBL] [Abstract][Full Text] [Related]
7. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
[TBL] [Abstract][Full Text] [Related]
8. Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM.
Hübinger A; Knode O; Susanto F; Reinauer H; Gries FA
Horm Metab Res; 1997 Sep; 29(9):436-9. PubMed ID: 9370111
[TBL] [Abstract][Full Text] [Related]
9. Glucose and fat utilization during intravenous administration of glucose and lipid emulsion in non-insulin-dependent diabetic patients.
Pelikánová T; Krausová Z; Kohout M; Válek J; Basĕ J
Nutrition; 1993; 9(1):18-22. PubMed ID: 8467106
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans.
Blümer RM; van der Crabben SN; Stegenga ME; Tanck MW; Ackermans MT; Endert E; van der Poll T; Sauerwein HP
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E613-7. PubMed ID: 18577692
[TBL] [Abstract][Full Text] [Related]
11. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
12. Nitrogen sparing effect of structured triglycerides containing both medium-and long-chain fatty acids in critically ill patients; a double blind randomized controlled trial.
Lindgren BF; Ruokonen E; Magnusson-Borg K; Takala J
Clin Nutr; 2001 Feb; 20(1):43-8. PubMed ID: 11161543
[TBL] [Abstract][Full Text] [Related]
13. Metabolic changes in elderly cancer patients after glucose ingestion. The role of tumor necrosis factor-alpha.
Gambardella A; Tortoriello R; Tagliamonte MR; Paolisso G; Varricchio M
Cancer; 1997 Jan; 79(1):177-84. PubMed ID: 8988743
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular triglyceride content is increased in IDDM.
Ebeling P; Essén-Gustavsson B; Tuominen JA; Koivisto VA
Diabetologia; 1998 Jan; 41(1):111-5. PubMed ID: 9498639
[TBL] [Abstract][Full Text] [Related]
15. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of ghrelin administration on glucose and lipid metabolism.
Vestergaard ET; Djurhuus CB; Gjedsted J; Nielsen S; Møller N; Holst JJ; Jørgensen JO; Schmitz O
J Clin Endocrinol Metab; 2008 Feb; 93(2):438-44. PubMed ID: 18042651
[TBL] [Abstract][Full Text] [Related]
17. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
18. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
Kruszynska YT; Olefsky JM; Frias JP
Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
[TBL] [Abstract][Full Text] [Related]
20. Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patients.
Avogaro A; Beltramello P; Marin R; Zambon S; Bonanome A; Biffanti S; Confortin L; Manzato E; Crepaldi G; Tiengo A
Atherosclerosis; 1995 Feb; 113(1):117-24. PubMed ID: 7755647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
